Modernization of Statistical Analytics

The Modernization of Statistical Analytics (MoA) Initiative aims to analyze methods for considering and validating novel statistical computing platforms to propose to Health Authorities.


A lack of evolution within the pharmaceutical industry’s analytic capabilities has given rise to inefficiency and a failure to leverage modern technologies within the clinical development space. Moreover, the limited regulatory perspective on this matter has become a barrier in implementing and leveraging newer analytical software capabilities.

By developing a foundational framework that increases Health Authorities’ confidence in the use of modernized statistical analysis and efficient technology across the industry, an opportunity exists to provide clarity and instill confidence in the use of modern software technologies, including those that generate outputs that support regulatory submissions.


  • Seeks to enable confident expansion of analytic infrastructure and tools considered valid for use within the regulatory space through increased Health Authority awareness
  • Empowers organizations to retain top talent in a workforce that now expects innovative, collaborative, and modern computing environments
  • Facilitates more dynamic and modernized analyses to be utilized, potentially allowing faster delivery of innovative products to patients

Available Solutions

For more information and to explore our solutions, visit our Initiative Solutions page.

Similar Initiatives

Intelligent Automation Opportunities in Pharmacovigilance

The Intelligent Automation Opportunities in Pharmacovigilance Initiative focuses on identifying how intelligent automation technologies can be used to better support execution of Pharmacovigilance activities/processes.